July 7, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral and knee-surgery implants, today announces its revenue for the first half of 2020. In € thousands – IFRS* 2020 2019 ΔTotal 1st quarter revenue 1,567 1,904 -18%2nd quarter      Spine (JAZZ®) 782 1,244 -37%Knee 246 670 -63%Total 2nd quarter revenue 1,029 1,915 -46%1st half      Spine (JAZZ®) 1,510 2,384 -37%Knee 1,085 1,434 -24%Total 1st half revenue 2,595 3,818 -32% * …